Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear CBS members, Greetings The Montreal Student Chapter of the Canadian Biomaterials Society is thrilled to invite you to a CBS Lunchtime webinar series talk and a lab tour on April 10th This event will feature an online presentation by Professor Darcy Wagner from McGill University at noon and an in-person lab tour starting at 4 30pm meet at RI-MUHC, Bloc E Atrium ...

Dear CBS Members, This is a friendly reminder that the abstract deadline for CBS2025 is today Submit your abstracts here...

Calling all ECR Faculty Members for Keynote Presentation Opportunities Dear CBS Members, A feature of CBS2025 will be presentations from current Early Career Researcher ECR faculty member highlighting their expertise and new research...

CBS2025 abstract submission deadline is extended until February 7th We know it is a busy time of year and so we are happy to announce that the CBS 2025 abstract submission deadline for the 39th Annual Meeting of the Canadian Biomaterial Society has been extended until February 7th, 2025 please note that this will be the last extension The CBS2025 Organizing Committee invites you to submit your abstracts related to biomaterials research through the Oxford Abstracts submission portal...

Tissue engineering may provide physiologically relevant models of the entire human body that may be used for studying biological mechanisms, as platforms for compound testing, and for cell-based treatment for diseases 1 ...

Transmission of diseases could occur by direct contact with surfaces contaminated by pathogens. Significant resources have been allocated to the cleaning and disinfection of surfaces against the spreading of corona virus during Covid-19 pandemic...

Bacterial infection is one of the most common complications in burnt, trauma, and chronic refractory wounds, leading to healing impediment...

Tissue engineered cell-scaffold constructs are often exposed to biologically relevant stimuli to encourage tissue maturation...

Continuous subcutaneous insulin infusion CSII is a treatment strategy for Type I diabetes mellitus T1D that relies on insulin infusion sets IIS to deliver insulin to the subcutaneous tissue via a polytetrafluoroethylene PTFE or stainless-steel cannula...